Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nathan

Showing results (371-380 of 635) with videos related to

Pageof 64
Sort By:
Diabetes|November 23, 2013
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributionsDavid M Nathan, Margaret Bayless, Patricia Cleary, et al.
Diabetes Care|July 29, 2006
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetologia|June 28, 2006
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesD M Nathan, J B Buse, M B Davidson, et al.
BMC Infectious Diseases|June 12, 2010
Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networksJames M McCaw, Kristian Forbes, Paula M Nathan, et al.
The New England Journal of Medicine|April 20, 2017
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes, David M Nathan, Ionut Bebu, et al.
Diabetes Care|October 25, 2017
Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783John M Lachin, Ionut Bebu, Richard M Bergenstal, et al.
The American Journal of Medicine|December 1, 1984
Decreased cognitive function in aging non-insulin-dependent diabetic patientsL C Perlmuter, M K Hakami, C Hodgson-Harrington, et al.
Diabetes Care|September 18, 2008
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trialJulie Lin, Robert J Glynn, Nader Rifai, et al.
Archives of Internal Medicine|July 29, 2009
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005), David M Nathan, Bernard Zinman, et al.
Problemy Endokrinologii|October 20, 2019
[Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. (A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes)]D M Nathan, J В Buse, M В Davidson, et al.
Pageof 64

Showing results (371-380 of 635) with videos related to

Sort By:
Pageof 64
Diabetes|November 23, 2013
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributionsDavid M Nathan, Margaret Bayless, Patricia Cleary, et al.
Diabetes Care|July 29, 2006
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetologia|June 28, 2006
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesD M Nathan, J B Buse, M B Davidson, et al.
BMC Infectious Diseases|June 12, 2010
Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networksJames M McCaw, Kristian Forbes, Paula M Nathan, et al.
The New England Journal of Medicine|April 20, 2017
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes, David M Nathan, Ionut Bebu, et al.
Diabetes Care|October 25, 2017
Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783John M Lachin, Ionut Bebu, Richard M Bergenstal, et al.
The American Journal of Medicine|December 1, 1984
Decreased cognitive function in aging non-insulin-dependent diabetic patientsL C Perlmuter, M K Hakami, C Hodgson-Harrington, et al.
Diabetes Care|September 18, 2008
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trialJulie Lin, Robert J Glynn, Nader Rifai, et al.
Archives of Internal Medicine|July 29, 2009
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005), David M Nathan, Bernard Zinman, et al.
Problemy Endokrinologii|October 20, 2019
[Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. (A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes)]D M Nathan, J В Buse, M В Davidson, et al.
Pageof 64